Dr Stefan Ryser joins Telik
This article was originally published in Scrip
Dr Stefan Ryser has been appointed to the newly created position of senior vice-president of corporate strategy at Telik (US). He has more than 20 years' executive and investment experience in the biotechnology and pharmaceutical industries, including 10 years as an independent Telik director. Dr Ryser most recently served as founding and managing partner of Bear Stearns Health Innoventures.
You may also be interested in...
The UK Department of Health and Social Care recently asked medical device and pharmaceutical companies to establish contingency measures in case of supply problems post-Brexit.
But the agency chose to fund only a small fraction of them, in part because of its hiring ability, and in part because all those employees would have cost an additional $98.7m in user fee revenue.